Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Peripheral Intervention Drug-Eluting Devices industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Market Segment by Product Application
Drug-Eluting Balloons
Drug-Eluting Stents
Finally, the report provides detailed profile and data information analysis of leading company.
Medtronic plc
St. Jude Medical, Inc.
Cardinal Health
Boston Scientific Corporation
C.R. Bard, Inc.
Abbott Laboratories
Terumo Corporation
Biosensors International Group Ltd.
B. Braun Melsungen AG
The Lubrizol Corporation
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Peripheral Intervention Drug-Eluting Devices consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Peripheral Intervention Drug-Eluting Devices market by identifying its various subsegments.
3.Focuses on the key global Peripheral Intervention Drug-Eluting Devices manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Peripheral Intervention Drug-Eluting Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Peripheral Intervention Drug-Eluting Devices submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Peripheral Intervention Drug-Eluting Devices Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Peripheral Intervention Drug-Eluting Devices Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Peripheral Intervention Drug-Eluting Devices Segment by Type
2.1.1 Plain Old Balloon Angioplasty (POBA)
2.1.2 Percutaneous Transluminal Angioplasty (PTA)
2.2 Market Analysis by Application
2.2.1 Drug-Eluting Balloons
2.2.2 Drug-Eluting Stents
2.3 Global Peripheral Intervention Drug-Eluting Devices Market Comparison by Regions (2017-2027)
2.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size (2017-2027)
2.3.2 North America Peripheral Intervention Drug-Eluting Devices Status and Prospect (2017-2027)
2.3.3 Europe Peripheral Intervention Drug-Eluting Devices Status and Prospect (2017-2027)
2.3.4 Asia-pacific Peripheral Intervention Drug-Eluting Devices Status and Prospect (2017-2027)
2.3.5 South America Peripheral Intervention Drug-Eluting Devices Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Peripheral Intervention Drug-Eluting Devices Industry Impact
2.5.1 Peripheral Intervention Drug-Eluting Devices Business Impact Assessment - Covid-19
2.5.2 Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Peripheral Intervention Drug-Eluting Devices Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
3.5 Top 10 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
3.7 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Peripheral Intervention Drug-Eluting Devices Industry Key Manufacturers
4.1 Medtronic plc
4.1.1 Company Details
4.1.2 Medtronic plc Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Medtronic plc News
4.2 St. Jude Medical, Inc.
4.2.1 Company Details
4.2.2 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.2.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 St. Jude Medical, Inc. News
4.3 Cardinal Health
4.3.1 Company Details
4.3.2 Cardinal Health Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.3.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Cardinal Health News
4.4 Boston Scientific Corporation
4.4.1 Company Details
4.4.2 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.4.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Boston Scientific Corporation News
4.5 C.R. Bard, Inc.
4.5.1 Company Details
4.5.2 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.5.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 C.R. Bard, Inc. News
4.6 Abbott Laboratories
4.6.1 Company Details
4.6.2 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.6.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Abbott Laboratories News
4.7 Terumo Corporation
4.7.1 Company Details
4.7.2 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.7.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Terumo Corporation News
4.8 Biosensors International Group Ltd.
4.8.1 Company Details
4.8.2 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.8.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Biosensors International Group Ltd. News
4.9 B. Braun Melsungen AG
4.9.1 Company Details
4.9.2 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.9.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 B. Braun Melsungen AG News
4.10 The Lubrizol Corporation
4.10.1 Company Details
4.10.2 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification
4.10.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 The Lubrizol Corporation News
5 Global Peripheral Intervention Drug-Eluting Devices Sales Categorized by Regions
5.1 Global Peripheral Intervention Drug-Eluting Devices Revenue, Sales and Market Share by Regions
5.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Regions (2017-2022)
5.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Regions (2017-2022)
5.2 North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
5.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
5.5 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
6 North America Peripheral Intervention Drug-Eluting Devices Market Size Categorized by Countries
6.1 North America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
6.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
6.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
6.1.3 United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
6.1.4 Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
6.1.5 Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
6.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (Value) by Manufacturers
6.3 North America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2017-2022)
6.4 North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
7 Europe Peripheral Intervention Drug-Eluting Devices Market Size Categorized by Countries
7.1 Europe Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
7.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
7.1.3 Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.1.4 UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.1.5 France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.1.6 Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.1.7 Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.1.8 Spain Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
7.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (Value) by Manufacturers
7.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2017-2022)
7.4 Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
8 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Size Categorized by Countries
8.1 Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
8.1.3 China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.1.4 South Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.1.5 Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.1.6 Australia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.1.7 India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue (Value) by Manufacturers
8.3 Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
9 South America Peripheral Intervention Drug-Eluting Devices Market Size Categorized by Countries
9.1 South America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
9.1.1 South America Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
9.1.2 South America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
9.1.3 Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
9.2 South America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2017-2022)
9.3 South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
10 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Size Categorized by Countries
10.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
10.1.3 GCC Countries Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
10.1.4 Turkey Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
10.1.5 Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
10.1.6 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type
10.3 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
11 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Type
11.1 Global Peripheral Intervention Drug-Eluting Devices Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2017-2022)
11.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2017-2022)
11.2 Plain Old Balloon Angioplasty (POBA) Sales Growth Rate and Price
11.2.1 Global Plain Old Balloon Angioplasty (POBA) Sales Growth Rate (2017-2022)
11.2.2 Global Plain Old Balloon Angioplasty (POBA) Price (2017-2022)
11.3 Percutaneous Transluminal Angioplasty (PTA) Sales Growth Rate and Price
11.3.1 Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth Rate (2017-2022)
11.3.2 Global Percutaneous Transluminal Angioplasty (PTA) Price (2017-2022)
12 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Application
12.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2017-2022)
12.2 Drug-Eluting Balloons Sales Growth Rate (2017-2022)
12.3 Drug-Eluting Stents Sales Growth Rate (2017-2022)
13 Global Peripheral Intervention Drug-Eluting Devices Market Forecast
13.1 Global Peripheral Intervention Drug-Eluting Devices Revenue, Sales and Growth Rate (2022-2027)
13.2 Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions (2022-2027)
13.2.1 North America Peripheral Intervention Drug-Eluting Devices Market Forecast (2022-2027)
13.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecast (2022-2027)
13.2.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecast (2022-2027)
13.2.4 South America Peripheral Intervention Drug-Eluting Devices Market Forecast (2022-2027)
13.2.5 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Forecast (2022-2027)
13.3 Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2022-2027)
13.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2022-2027)
13.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2022-2027)
13.4 Peripheral Intervention Drug-Eluting Devices Market Forecast by Application (2022-2027)
13.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2022-2027)
13.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Peripheral Intervention Drug-Eluting Devices Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Peripheral Intervention Drug-Eluting Devices Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Peripheral Intervention Drug-Eluting Devices
Figure Market Concentration Ratio and Market Maturity Analysis of Peripheral Intervention Drug-Eluting Devices
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Peripheral Intervention Drug-Eluting Devices Market Size by Type
Figure Global Market Share of Peripheral Intervention Drug-Eluting Devices by Type in 2021
Figure Plain Old Balloon Angioplasty (POBA) Picture
Figure Percutaneous Transluminal Angioplasty (PTA) Picture
Table Global Peripheral Intervention Drug-Eluting Devices Market Size (Volume) by Application
Figure Drug-Eluting Balloons Picture
Figure Drug-Eluting Stents Picture
Table Global Peripheral Intervention Drug-Eluting Devices Comparison by Regions (M USD) 2017-2027
Figure Global Peripheral Intervention Drug-Eluting Devices Market Size (Million US$) (2017-2027)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Peripheral Intervention Drug-Eluting Devices Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2017-2022)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2021
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2017-2022)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2021
Table Global Peripheral Intervention Drug-Eluting Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
Table Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Type
Table Mergers & Acquisitions Planning
Table Medtronic plc Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Medtronic plc
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Medtronic plc 2017-2022
Table Medtronic plc Main Business
Table Medtronic plc Recent Development
Table St. Jude Medical, Inc. Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of St. Jude Medical, Inc.
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of St. Jude Medical, Inc. 2017-2022
Table St. Jude Medical, Inc. Main Business
Table St. Jude Medical, Inc. Recent Development
Table Cardinal Health Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Cardinal Health
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cardinal Health 2017-2022
Table Cardinal Health Main Business
Table Cardinal Health Recent Development
Table Boston Scientific Corporation Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Boston Scientific Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Boston Scientific Corporation 2017-2022
Table Boston Scientific Corporation Main Business
Table Boston Scientific Corporation Recent Development
Table C.R. Bard, Inc. Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of C.R. Bard, Inc.
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of C.R. Bard, Inc. 2017-2022
Table C.R. Bard, Inc. Main Business
Table C.R. Bard, Inc. Recent Development
Table Abbott Laboratories Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Abbott Laboratories
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2017-2022
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Terumo Corporation Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Terumo Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Terumo Corporation 2017-2022
Table Terumo Corporation Main Business
Table Terumo Corporation Recent Development
Table Biosensors International Group Ltd. Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of Biosensors International Group Ltd.
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biosensors International Group Ltd. 2017-2022
Table Biosensors International Group Ltd. Main Business
Table Biosensors International Group Ltd. Recent Development
Table B. Braun Melsungen AG Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of B. Braun Melsungen AG
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of B. Braun Melsungen AG 2017-2022
Table B. Braun Melsungen AG Main Business
Table B. Braun Melsungen AG Recent Development
Table The Lubrizol Corporation Company Profile
Table Peripheral Intervention Drug-Eluting Devices Product Introduction, Application and Specification of The Lubrizol Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of The Lubrizol Corporation 2017-2022
Table The Lubrizol Corporation Main Business
Table The Lubrizol Corporation Recent Development
Figure Global Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table Global Peripheral Intervention Drug-Eluting Devices Sales by Regions (2017-2022)
Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Regions in 2021
Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2017-2022)
Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2021
Figure North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2017-2022)
Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2021
Table North America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2017-2022)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2021
Figure United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2021)
Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2021
Table North America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022)
Table North America Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2017-2022)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2017-2022)
Figure Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2021
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2017-2022)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2021
Figure Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Spain Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2021)
Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2021
Table Europe Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2017-2022)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2021
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2021
Figure China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure South Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Australia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2021)
Figure Asia-pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022)
Table Asia-pacific Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2017-2022)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2017-2022)
Figure South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2019
Table South America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2017-2022)
Figure South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2019
Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales by Application (2017-2022)
Table South America Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2017-2022)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2019
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2019
Figure GCC Countries Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Type (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Type (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2017-2022)
Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Application
Medtronic plc
St. Jude Medical, Inc.
Cardinal Health
Boston Scientific Corporation
C.R. Bard, Inc.
Abbott Laboratories
Terumo Corporation
Biosensors International Group Ltd.
B. Braun Melsungen AG
The Lubrizol Corporation
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)